Open Access

Hypoxia induces the expression of TET enzymes in HepG2 cells

  • Authors:
    • Guofu Lin
    • Wenyu Sun
    • Zhi Yang
    • Jinshuai Guo
    • Haiyang Liu
    • Jian Liang
  • View Affiliations

  • Published online on: September 26, 2017     https://doi.org/10.3892/ol.2017.7063
  • Pages:6457-6462
  • Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: PDF 0 views | HTML 0 views
0

Abstract

Hypoxia promotes tumor malignancy in solid tumors. One key mechanism by which this occurs is via epigenetic alteration. The present study demonstrates that hypoxia upregulates the expression of the ten‑eleven‑translocation 5‑methylcytosine dioxygenase (TET) enzymes, which catalyze the conversion of 5‑methylcytosine to 5‑hydroxymethylcytosine (5‑hmC), thereby leading to elevated cellular 5‑hmC levels in hepatoblastoma HepG2 cells. Hypoxia inducible factor‑1α (HIF‑1α) is the main transcription factor activated by hypoxia. A chemical inducer of HIF‑1α, CoCl2, also increases the expression of TET enzymes. Knockdown of HIF‑1α attenuates the hypoxia‑induced expression of TET enzymes. These results indicate that hypoxia controls DNA methylation through HIF‑1α‑mediated TET enzyme regulation in HepG2 cells.

Related Articles

Journal Cover

December 2017
Volume 14 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Lin, G., Sun, W., Yang, Z., Guo, J., Liu, H., & Liang, J. (2017). Hypoxia induces the expression of TET enzymes in HepG2 cells. Oncology Letters, 14, 6457-6462. https://doi.org/10.3892/ol.2017.7063
MLA
Lin, G., Sun, W., Yang, Z., Guo, J., Liu, H., Liang, J."Hypoxia induces the expression of TET enzymes in HepG2 cells". Oncology Letters 14.6 (2017): 6457-6462.
Chicago
Lin, G., Sun, W., Yang, Z., Guo, J., Liu, H., Liang, J."Hypoxia induces the expression of TET enzymes in HepG2 cells". Oncology Letters 14, no. 6 (2017): 6457-6462. https://doi.org/10.3892/ol.2017.7063